CHICAGO | April 6, 2021
The American Lung Association is working to end the COVID-19 pandemic and encouraging widespread adoption of vaccination. To help ensure vaccination benefit across all populations, the American Lung Association has funded a new research study to examine the efficacy of COVID vaccination for transplant recipients.
The new study, “Immune response of lung transplant recipients to SARS-CoV-2 vaccination,” is led by a team of investigators from Harvard and Massachusetts General. Marcia B. Goldberg, M.D., whose husband is a heart transplant recipient, pursued the study with her colleagues Jacob Lemieux, M.D., Ph.D., and Amy Li, M.D., Ph.D., after noting that the current vaccination trials did not assess the efficacy of COVID vaccination for transplant recipients.
For Biogen, it s been a rough ride - The Boston Globe
bostonglobe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bostonglobe.com Daily Mail and Mail on Sunday newspapers.
‘Be very vigilant’: Baker says highly infectious COVID-19 variant is likely already in Mass. Hanna Krueger © Craig F. Walker/Globe Staff Nicholas McKenzie of Cataldo Ambulance Service conducted a COVID-19 test on Tuesday outside the Randolph Intergenerational Community Center.
Governor Charlie Baker on Tuesday asked residents to redouble their efforts to control the spread of the coronavirus based on the assumption that a new, more contagious form of the virus has arrived in the state, threatening a further surge in cases and deaths.
”There’d be no reason not to [believe it’s here], given the contagious nature of this new variant,” Baker said in Springfield, a day after the first case of the new strain was reported in New York. He reiterated the importance of masks and social distancing and urged residents to be “very vigilant and careful and cautious about our physical engagement with other people.”
1. “An Evolving Situation”
There are three moments in the yearlong catastrophe of the
COVID-19 pandemic when events might have turned out differently. The first occurred on January 3, 2020, when Robert Redfield, the director of the Centers for Disease Control and Prevention, spoke with George Fu Gao, the head of the Chinese Center for Disease Control and Prevention, which was modelled on the American institution. Redfield had just received a report about an unexplained respiratory virus emerging in the city of Wuhan.
The field of public health had long been haunted by the prospect of a widespread respiratory-illness outbreak like the 1918 influenza pandemic, so Redfield was concerned. Gao, when pressed, assured him that there was no evidence of human-to-human transmission. At the time, the theory was that each case had arisen from animals in a “wet” market where exotic game was sold. When Redfield learned that, among twenty-seven reported cases, there were several famil
Health 14th Dec 2020 6:51 AM A single event in Boston has been linked to up to 300,000 coronavirus cases across the US and even some in Australia, according to scientists. Biotechnology company Biogen s medical conference was held on February 26 and 27, with contact tracers reporting there were just over 100 cases of COVID-19 from the event up until November 1. However a team of scientists tracking the ongoing spread of the virus say the real figure is between 205,000 and 300,000, with the findings published in the journal
Science. The conference marked the beginning of a significant spread throughout Boston, the US and even the rest of the world, with scientists noting linked cases began spreading to other US cities in early March, and even ventured as far as Australia and Slovakia. The first cases of human-to-human transmission in Australia were recorded in early March.
vimarsana © 2020. All Rights Reserved.